Teva reflects robust future for generic drug makers

11/5/2007 | CNNMoney

The growing demand for more affordable drugs around the world is key to Teva Pharmaceutical Industries Ltd.'s promising performance in the coming years, according to analysts. Teva, the world's largest generic drug maker, aggressively pursues legal challenges to patent-protected drugs in order to get its own versions into the market, and consequently it has more than 150 abbreviated new drug applications pending with the FDA.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC
Associate Director, Compliance & Ethics, US Operations Ops II
Bristol-Myers Squibb
Plainsboro, NJ
Senior Associate, Health Economics - Heart Valve Therapy
Edwards Lifesciences
Irvine, CA